Substance / Medication

Nandrolone decanoate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Nandrolone Decanoate: Use, Abuse and Side Effects.
Patanè Federico Giuseppe, Liberto Aldo, Maria Maglitto Andreana Nicoletta et al. · Medicina (Kaunas) · 2020
PMID: 33187340Meta-AnalysisFull text (PMC)
The impact of nandrolone decanoate on the central nervous system.
Busardò Francesco P, Frati Paola, Sanzo Mariantonia Di et al. · Curr Neuropharmacol · 2015
PMID: 26074747Meta-AnalysisFull text (PMC)
Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease.
Eiam-Ong Somchai, Buranaosot Somphon, Eiam-Ong Somchit et al. · J Ren Nutr · 2007
PMID: 17462549RCT
Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis.
Sheashaa Hussein, Abdel-Razek Waleed, El-Husseini Amr et al. · Nephron Clin Pract · 2005
PMID: 15703460RCT
Cytoarchitecture of steroid dependent target tissues after testosterone administration compared to nandrolone decanoate in castrated rats in the aim of Hershberger bio test.
Cristina Romeo Teodor, Hanganu Flavia, Brezovan Diana et al. · Rom J Morphol Embryol · 2014
PMID: 25607397Observational
Beneficial effects of nandrolone decanoate in wasting associated with HIV.
Saha Bibhuti, Rajadhyaksha Girish C, Ray Subrat K · J Indian Med Assoc · 2009
PMID: 19886384Observational
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
Gold J, Batterham M J, Rekers H et al. · HIV Med · 2006
PMID: 16494628Observational
The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats.
Kurling Sanna, Kankaanpää Aino, Ellermaa Satu et al. · Brain Res · 2005
PMID: 15862791Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Nandrolone decanoate (substance)
SNOMED CT
412253000
UMLS CUI
C0068395

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

2
Conditions
3
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Nandrolone decanoate — Conditions, Biomarkers & Specialists | Healos | Healos